Click Therapeutics Anticipates Pharma Will Begin Developing Digital Drugs From Clinical Stage
FDA Draft Guidance And Exploding GLP-1 R&D Create New Horizons For Digital Therapeutics
Leading digital therapeutic maker’s CEO David Benshoof Klein and CMO Shaheen Lakhan discuss outlook on the DTx space, priorities going forward, and what makes Click a standout player in a changing game.
